The sequencing of the zebrafish genome should be completed by the end of 20
02. Direct assignment of function on the basis of this information would be
facilitated by the development of a rapid, targeted 'knockdown' technology
in this model vertebrate. We show here that antisense, morpholino-modified
oligonucleotides(1) (morpholinos) are effective and specific translational
inhibitors in zebrafish. We generated phenocopies of mutations of the gene
s no tail (ref. 2), chordin (ref. 3), one-eyed-pinhead (ref. 4), nacre (ref
. 5) and sparse (ref. 6), removing gene function from maternal through post
-segmentation and organogenesis developmental stages. We blocked expression
from a ubiquitous green fluorescent protein (GFP) transgene, showing that,
unlike tissue-restricted limitations found with RNA-based interference in
the nematode(7), all zebrafish cells readily respond to this technique. We
also developed also morpholino-based zebrafish models of human disease. Mor
pholinos targeted to the uroporphyrinogen decarboxylase gene(8) result in e
mbryos with hepatoerythropoietic porphyria. We also used morpholinos for th
e determination of new gene functions. We showed that embryos with reduced
sonic hedgehog (ref. 9) signalling and reduced tiggy-winkle hedgehog(ref. 1
0) function exhibit partial cyclopia and other specific midline abnormaliti
es, providing a zebrafish genetic model for the common human disorder holop
rosencephaly. Conserved vertebrate processes and diseases are now amenable
to a systematic, in vivo, reverse-genetic paradigm using zebrafish embryos.